The Effect of PPI in Preventing Gastroesophageal Reflux Disease of Seafarers
Status:
Not yet recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
In view of the high incidence of GERD among seafarers and its continuing impact on the life
quality of seafarers, it is necessary to use preventive treatment. At the same time, because
both mental and psychological factors and changes in intestinal flora may play a certain role
in the development and treatment of GERD, this project intends to take the seafarers involved
in this scientific expedition as the participants to explore the effect of PPI discontinuous
therapy in preventing gastroesophageal reflux disease of seafarers, a special occupational
group and the changes in the mental and psychological status and intestinal flora of this
group of people after PPI therapy.